Marc Schwartz

7PUBLICATIONS
67CO-AUTHORS
Molecular targetsInnate immunityMedical virologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 29, 2026
Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors.

|Dec 24, 2025
Multiomic Immune Profiling of Pediatric Transplant Recipients Identifies Cell States Associated with Vaccine Response.

Johannes Wedel, Ying Tang, Bayan Alsairafi

|Oct 07, 2024
In Vivo CRISPR Screening Reveals CHD7 as a Positive Regulator of Short-lived Effector Cells.

Martin W LaFleur, Jasmin M D'Andrea, Dillon G Patterson

|Sep 17, 2024
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control.

Sarah A Weiss, Amy Y Huang, Megan E Fung

|Feb 27, 2024
Framework for in vivo T cell screens.

Lauren E Milling, Samuel C Markson, Qin Tjokrosurjo

|Aug 21, 2023
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease.

Holly Wobma, Malika Kapadia, Haesook T Kim

Pageof 2

Frequent Collaborators

4 joint publications

John G Doench

4 joint publications

Martin W LaFleur

3 joint publications

Arlene H Sharpe

3 joint publications

Nir Hacohen